vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TechTarget, Inc. (TTGT). Click either name above to swap in a different company.

TechTarget, Inc. is the larger business by last-quarter revenue ($140.7M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). TechTarget, Inc. runs the higher net margin — -6.7% vs -38.1%, a 31.3% gap on every dollar of revenue.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

TechTarget, Inc. is an American company that offers data-driven marketing services to business-to-business technology vendors.

PRCT vs TTGT — Head-to-Head

Bigger by revenue
TTGT
TTGT
1.7× larger
TTGT
$140.7M
$83.1M
PRCT
Higher net margin
TTGT
TTGT
31.3% more per $
TTGT
-6.7%
-38.1%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
TTGT
TTGT
Revenue
$83.1M
$140.7M
Net Profit
$-31.6M
$-9.5M
Gross Margin
64.9%
63.8%
Operating Margin
-4.1%
-10.5%
Net Margin
-38.1%
-6.7%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TTGT
TTGT
Q1 26
$83.1M
Q4 25
$76.4M
$140.7M
Q3 25
$83.3M
$122.3M
Q2 25
$79.2M
$119.9M
Q1 25
$69.2M
$103.9M
Q4 24
$68.2M
Q3 24
$58.4M
$62.9M
Q2 24
$53.4M
Net Profit
PRCT
PRCT
TTGT
TTGT
Q1 26
$-31.6M
Q4 25
$-29.8M
$-9.5M
Q3 25
$-21.4M
$-76.8M
Q2 25
$-19.6M
$-398.7M
Q1 25
$-24.7M
$-523.4M
Q4 24
$-18.9M
Q3 24
$-21.0M
$-17.4M
Q2 24
$-25.6M
Gross Margin
PRCT
PRCT
TTGT
TTGT
Q1 26
64.9%
Q4 25
60.6%
63.8%
Q3 25
64.8%
61.3%
Q2 25
65.4%
57.3%
Q1 25
63.9%
57.5%
Q4 24
64.0%
Q3 24
63.2%
62.1%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
TTGT
TTGT
Q1 26
-4.1%
Q4 25
-40.6%
-10.5%
Q3 25
-27.8%
-88.2%
Q2 25
-28.0%
-342.1%
Q1 25
-39.7%
-474.5%
Q4 24
-28.9%
Q3 24
-38.4%
-22.9%
Q2 24
-50.3%
Net Margin
PRCT
PRCT
TTGT
TTGT
Q1 26
-38.1%
Q4 25
-39.1%
-6.7%
Q3 25
-25.7%
-62.8%
Q2 25
-24.7%
-332.4%
Q1 25
-35.8%
-503.8%
Q4 24
-27.6%
Q3 24
-35.9%
-27.7%
Q2 24
-48.0%
EPS (diluted)
PRCT
PRCT
TTGT
TTGT
Q1 26
$-0.56
Q4 25
$-0.54
$-0.09
Q3 25
$-0.38
$-1.07
Q2 25
$-0.35
$-5.58
Q1 25
$-0.45
$-7.32
Q4 24
$-0.34
Q3 24
$-0.40
$-0.42
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TTGT
TTGT
Cash + ST InvestmentsLiquidity on hand
$245.6M
$40.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$594.6M
Total Assets
$487.1M
$937.3M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TTGT
TTGT
Q1 26
$245.6M
Q4 25
$286.5M
$40.6M
Q3 25
$294.3M
$46.3M
Q2 25
$302.7M
$61.7M
Q1 25
$316.2M
$78.7M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
PRCT
PRCT
TTGT
TTGT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TTGT
TTGT
Q1 26
$347.7M
Q4 25
$365.9M
$594.6M
Q3 25
$380.3M
$597.9M
Q2 25
$385.8M
$668.7M
Q1 25
$389.2M
$1.1B
Q4 24
$402.2M
Q3 24
$241.2M
$134.2M
Q2 24
$251.8M
Total Assets
PRCT
PRCT
TTGT
TTGT
Q1 26
$487.1M
Q4 25
$508.1M
$937.3M
Q3 25
$511.5M
$987.4M
Q2 25
$513.1M
$1.1B
Q1 25
$519.4M
$1.5B
Q4 24
$534.0M
Q3 24
$374.1M
$0
Q2 24
$374.4M
Debt / Equity
PRCT
PRCT
TTGT
TTGT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TTGT
TTGT
Operating Cash FlowLast quarter
$11.8M
Free Cash FlowOCF − Capex
$11.6M
FCF MarginFCF / Revenue
8.2%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$15.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TTGT
TTGT
Q1 26
Q4 25
$-10.3M
$11.8M
Q3 25
$-6.6M
$-9.1M
Q2 25
$-15.0M
$1.5M
Q1 25
$-17.0M
$12.2M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
PRCT
PRCT
TTGT
TTGT
Q1 26
Q4 25
$-12.2M
$11.6M
Q3 25
$-9.5M
$-9.3M
Q2 25
$-17.8M
$1.4M
Q1 25
$-18.8M
$12.2M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PRCT
PRCT
TTGT
TTGT
Q1 26
Q4 25
-15.9%
8.2%
Q3 25
-11.4%
-7.6%
Q2 25
-22.5%
1.2%
Q1 25
-27.2%
11.7%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PRCT
PRCT
TTGT
TTGT
Q1 26
Q4 25
2.4%
0.1%
Q3 25
3.4%
0.1%
Q2 25
3.5%
0.0%
Q1 25
2.7%
0.0%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TTGT
TTGT

Segment breakdown not available.

Related Comparisons